Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study

Autor: Marie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, Constance Lahuna, Benoit De Renzis, Diane Kottler, Laurent Voillat, Sophie Dimicoli-Salazar, Anne Banos, Marie-Paule Chauveheid, Jean-François Alexandra, Eric Grignano, François Liferman, Mathilde Laborde, Jonathan Broner, Marc Michel, Olivier Lambotte, Kamel Laribi, Marie-Dominique Venon, Bertrand Dussol, Nihal Martis, Sylvain Thepot, Sophie Park, David Couret, Marielle Roux-Sauvat, Louis Terriou, Eric Hachulla, Cécile Bally, Joris Galland, Jean-Sébastien Allain, Anne Parcelier, Pierre Peterlin, Judith Cohen-Bittan, Alexis Regent, Felix Ackermann, Julien Le Guen, Caroline Algrin, Pierre Charles, Etienne Daguindau, Xavier Puechal, Bertrand Dunogue, Claire Blanchard-Delaunay, Odile Beyne-Rauzy, Vincent Grobost, Jean Schmidt, Thomas Le Gallou, Georgeta Dubos-Lascu, Anne Sonet, Guillaume Denis, Frédérique Roy-Peaud, Pierre Fenaux, Lionel Adès, Olivier Fain, Arsène Mekinian

Publikováno v: Clinical and experimental rheumatology
Clinical and experimental rheumatology, 2022, 40 (7), pp.1336-1342. ⟨10.55563/clinexprheumatol/nbn38d⟩

International audience; Objectives: Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) are associated with systemic inflammatory and autoimmune diseases (SIADs) in 10-30% of cases. The aims of this study were (i) to evaluate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e346c937133a7bf37ca826a93c2149d4
https://pubmed.ncbi.nlm.nih.gov/35579092

Place des agents hypométhylants dans les hémopathies malignes de l’enfant : étude rétrospective de l’administration d’Azacitidine dans trois centres d’hématologie d’Île-de-France

Autor: SAUCIER, Émilie

Publikováno v: Médecine humaine et pathologie. 2019

Purpose: data on the interest of hypomethylating agents in pediatric hematologic malignancies are missing. Administration of Azacitidine (Aza), regarding indication, efficacy and toxicity, in a cohort of children and young adults, has been studied. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2592::9438d81bea199993bc15c061c21754d6
https://dumas.ccsd.cnrs.fr/dumas-03190565/file/ThExe_SAUCIER_Emilie_DUMAS.pdf

Syndromes myélodysplasiques avec trisomie 8 isolée : une forme fréquemment associée à des caractéristiques myéloprolifératives ?

Autor: Drevon, Louis

Publikováno v: Médecine humaine et pathologie. 2019

Isolated trisomy 8 (+8) is a frequent cytogenetic abnormality in the myelodysplastic syndromes (MDS), but its characteristics are poorly reported. We performed a retrospective study of patients with isolated +8, classified or reclassified as MDS acco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2592::4034bea09265bd7617f76a9ac71c455d
https://dumas.ccsd.cnrs.fr/dumas-02498358

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies

Autor: Laurence Clement, Yves Beguin, Alain Duhamel, Pierre Fenaux, Eric Deconinck, Marie-Thérèse Rubio, Ibrahim Yakoub-Agha, Aline Schmidt-Tanguy, Claude-Eric Bulabois, Pierre Bories, Jean-Pierre Marolleau, Gandhi Damaj, Jean El Cheikh, Mohamad Mohty, Lionel Ades, Stephane Vigouroux, Zora Marjanovic, Faeyzeh Legrand, Natacha Maillard, Charles Dauriac, Anne Huynh, Jérôme Cornillon, Jacques-Olivier Bay, Gaelle Guillerm, Sophie Park, Nathalie Fegueux, Mauricette Michallet, Marie Robin, Alice Garnier, Federico Garnier

Publikováno v: Journal of Clinical Oncology
Journal of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (36), pp.4533-40. 〈10.1200/JCO.2012.44.3499〉
Journal of Clinical Oncology, American Society of Clinical Oncology, 2012, 30 (36), pp.4533-40. ⟨10.1200/JCO.2012.44.3499⟩

Purpose To investigate the impact of prior-to-transplantation azacitidine (AZA) on patient outcome after allogeneic stem-cell transplantation (alloSCT) for myelodysplastic syndrome (MDS). Patients and Methods Of the 265 consecutive patients who under

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be694ab560db08eec073e5172cb47ac7
https://www.hal.inserm.fr/inserm-00821506/document

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

Autor: Luis Isola, Daniel J. Weisdorf, Mitchell S. Cairo, John R. Wingard, Robert Peter Gale, Anna Hassebroek, Michael Boyiadzis, Mary M. Horowitz, David A. Jacobsohn, Mary E.D. Flowers, Corey Cutler, Thomas R. Klumpp, Harry C. Schouten, Brian J. Bolwell, Stella Santarone, Roger H. Herzig, Mukta Arora, John P. Klein, Effie W. Petersdorf, Joseph H. Antin, Stephen R. Spellman, Steven Z. Pavletic, Jean-Yves Cahn, Alvaro Urbano-Ispizua, Stephanie J. Lee

Publikováno v: Blood, 118(16), 4472-4479. The American Society of Hematology
Blood
Blood, American Society of Hematology, 2011, 118 (16), pp.4472-9. ⟨10.1182/blood-2011-04-349068⟩

There is a paucity of information regarding the factors that affect nonrelapse mortality (NRM) and overall survival among children that develop chronic graft-versus-host disease (cGVHD). We performed multivariate analyses using data from the Center f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a60336671f5ffa308eb3b6b826fb76
https://cris.maastrichtuniversity.nl/en/publications/b73b1749-3a52-4042-9dfa-8d98f53ab8fa